Mo1116 The Efficacy and Safety of Rifaximin vs. Vancomycin in the Treatment of Mild to Moderate C. difficile Infection: A Randomized Double-Blind Active Comparator Trial
Autor: | Pardi, Darrell S., Brennan, Robert, Spinnell, Mitchell, Gareca, Marcelo G., Greenberg, Eugene, Tian, Wei, Bortey, Enoch, Forbes, William P., DuPont, Herbert L. |
---|---|
Zdroj: | In Gastroenterology May 2012 142(5) Supplement 1:S |
Databáze: | ScienceDirect |
Externí odkaz: |